Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsendocrinology-diabetes-and-growth

Paeds SAQs · endocrinology-diabetes-and-growth

Constitutional delay and familial short stature — formative SAQs

Formative SAQs on distinguishing familial short stature from constitutional delay of growth and puberty, reading the growth-chart trajectory and bone age, excluding the pathological mimics, and counselling the distressed adolescent.

20 marks30 min2 min readVerification in progress

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
On this page
Study tools

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
Prompt
Short stature and the normal variants

SAQ 1 (10)

A seven-year-old boy is referred because he is the shortest in his class. Both parents are short (father 162 cm, mother 150 cm). His birth weight was 3.1 kg at term. His height tracks just below the third centile and has done so since toddlerhood, with a normal growth velocity. His bone age equals his chronological age. [1] [2]

a) Define short stature and calculate this child's approximate mid-parental (target) height range. State the diagnosis you favour and the single investigation that confirms it. (3 marks) [1]

b) Explain why the bone age is the discriminator between familial short stature and constitutional delay of growth and puberty, and state the expected bone age in each. (3 marks) [2]

c) Name the focused blood panel you would send to exclude the pathological mimics, and give one reason for each test. (3 marks) [1]

d) Explain why growth hormone is not indicated for this child, and state the principle that governs its use in the normal variants. (1 mark) [2]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References4ShowHide
  1. [1]Caro R, Savel P, Moss PI. Evaluation of Short and Tall Stature in Children. Am Fam Physician, 2025.PMID 40531152
  2. [2]Wit JM, Oostdijk W. Novel approaches to short stature therapy. Best Pract Res Clin Endocrinol Metab, 2015.PMID 26051296
  3. [3]Butler G, Purushothaman P. Delayed puberty. Minerva Pediatr, 2020.PMID 32748610
  4. [4]Luciano TM, Stecchini MF, Antonini SRR. Boys with constitutional delay of growth and puberty developed spontaneous puberty and reached standard adult height without pharmacological therapy. J Pediatr (Rio J), 2025.PMID 40784365
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousCongenital hypothyroidism — formative SAQsendocrinology-diabetes-and-growthNextCushing syndrome in children — formative SAQsendocrinology-diabetes-and-growth